뒤로
Ascentage Pharma Group International(ASPHF) 가격
ASPHF 주가 차트
ASPHF 수입
Ascentage Pharma Group International
$8.48
0%
$0
종가: Jan 23, 16:00:00 GMT-5
$8.48
0%
$0
애프터마켓: Jan 23, 20:00:00 GMT-5
주요 통계
이전 종가
$8.48
시가
$8.48
일일 범위
$8.48 - $8.48
52주 범위
$5.42 - $10.65
거래량
100
평균 거래량
58
EPS(TTM)
-0.52
배당수익률
--
시가총액
$3.1B
ASCENTAGE PHARMA GROUP INTL란 무엇인가요?
Ascentage Pharma Group International Co., Ltd. is a clinical-stage biotechnology company. The company is headquartered in Suzhou, Jiangsu and currently employs 605 full-time employees. The company went IPO on 2019-10-28. The firm's main products include Olverembatinib (HQP1351), Lisaftoclax (APG-2575), Alrizomadlin (APG-115), Pelcitoclax (APG-1252), APG-5918, and APG-2449. The firm's products are primarily used to treat chronic myeloid leukemia (CML), acute myeloid leukemia (AML), chronic lymphocytic leukemia (CLL), acute lymphoblastic leukemia (ALL), myelodysplastic syndrome (MDS) and multiple myeloma (MM). The firm primarily conducts its businesses in domestic market.